Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Altimmune (ALT) over the last 8 years, with Q2 2025 value amounting to $105.5 million.

  • Altimmune's Change in Acquisitions & Divestments rose 44127.69% to $105.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $170.4 million, marking a year-over-year increase of 9733.92%. This contributed to the annual value of $87.3 million for FY2024, which is 1471.05% down from last year.
  • Latest data reveals that Altimmune reported Change in Acquisitions & Divestments of $105.5 million as of Q2 2025, which was up 44127.69% from $38.0 million recorded in Q1 2025.
  • In the past 5 years, Altimmune's Change in Acquisitions & Divestments registered a high of $105.5 million during Q2 2025, and its lowest value of $14.0 million during Q1 2024.
  • Over the past 4 years, Altimmune's median Change in Acquisitions & Divestments value was $26.4 million (recorded in 2023), while the average stood at $31.5 million.
  • As far as peak fluctuations go, Altimmune's Change in Acquisitions & Divestments crashed by 5949.66% in 2024, and later soared by 44127.69% in 2025.
  • Altimmune's Change in Acquisitions & Divestments (Quarter) stood at $25.0 million in 2021, then grew by 3.38% to $25.9 million in 2023, then grew by 3.78% to $26.8 million in 2024, then soared by 293.18% to $105.5 million in 2025.
  • Its last three reported values are $105.5 million in Q2 2025, $38.0 million for Q1 2025, and $26.8 million during Q4 2024.